Sinocare Inc. · Changsha, Hunan

Sinocare Gold AQ Plus Blood Glucose Monitoring System

FDA-cleared gold-electrode glucose system: 0.8 uL sample, 5-second results

FDA 510(k) K170264 - Gold AQ Blood Glucose Monitoring System platform clearance (Changsha Sinocare, Inc., 2017); Plus-specific 510(k) coverage was not separately confirmedEN ISO 15197:2015 (per official Sinocare product page) Data confidence: high
Sinocare Gold AQ Plus Blood Glucose Monitoring System
Illustrative product graphic. Request the datasheet or current photography from the manufacturer.

Overview

The Gold AQ Plus is Sinocare's hospital-grade blood glucose monitoring system, built on a gold-electrode test strip and GDH-FAD amperometric chemistry with a wide 20%-70% haematocrit range. The Gold AQ Blood Glucose Monitoring System received FDA 510(k) clearance (K170264, Changsha Sinocare, Inc.), a rare credential among Chinese BGM brands. It combines a 0.8 uL sample volume, 5-second results and 500-result memory with a no-coding workflow for home and clinical use.

Key highlights

  • FDA 510(k)-cleared Gold AQ platform (K170264, 2017); measuring range 20-600 mg/dL
  • Requires only 0.8 uL of capillary or venous whole blood and reports a result in 5 seconds
  • Wide 20%-70% haematocrit range supported by gold-electrode test strips
  • Stores 500 blood glucose results plus 100 control-solution results; no coding required
  • Repeatability CV 2.0%-3.7%; 97.9% of lay-user results within +/-15% (n=105)
  • Runs on 2 AAA alkaline batteries for about 1,000 tests at 10-40 C and up to 10,100 ft

Technical parameters

25 published parameters, grouped. Source links are listed under “Data sources”.

Measurement

Measuring range20-600 mg/dL (1.1-33.3 mmol/L)
Test time5 seconds
Accuracy (lay-user study)97.9% of results >=75 mg/dL within +/-15%; 100% of results <75 mg/dL within +/-15 mg/dL (n=105)
Repeatability precisionCV 2.0%-3.7% across six glucose levels (30-600 mg/dL)
Measurement methodQuantitative amperometric GDH-FAD biosensor with gold electrode
Calibration / codingPlasma-calibrated, no coding (automatic)
Haematocrit range20%-70%
InterferenceNo significant interference from 28 tested substances; uric acid >10 mg/dL and ascorbic acid >3 mg/dL interfere
LinearityR2 0.9992-0.9998 across 16-610 mg/dL (3 strip lots)

Sample

Sample volume0.8 uL minimum
Sample typeFresh capillary whole blood (fingertip) and venous whole blood
Test strip storage1-30 C, 10-90% RH
Test strip stability24 months closed vial; 6 months open vial

Memory

Memory capacity500 blood glucose test results + 100 control solution results
Result flags"Lo" below 20 mg/dL; "Hi" above 600 mg/dL (not stored in memory)

Display

Measurement unitsmg/dL (mmol/L equivalent 1.1-33.3 published in worldwide listings)
Control auto-detectionAutomatically distinguishes 3 control-solution levels from whole blood

Power

Battery2 x AAA alkaline batteries
Battery lifeAbout 1,000 tests

Physical

Meter dimensions4.06 x 2.36 x 0.94 in

Environment

Operating conditions10-40 C, 10-90% RH (FDA-cleared range)
AltitudeUp to 10,100 ft (tested to 10,207 ft)

Regulatory

FDA classificationClass II, 21 CFR 862.1345, product code NBW, over-the-counter
FDA clearance510(k) K170264, cleared 5 October 2017 (Changsha Sinocare, Inc.)
StandardEN ISO 15197:2015 (per manufacturer product page)

Applications

  • 1Home self-monitoring of blood glucose for people with diabetes
  • 2Hospital ward and bedside blood glucose testing by healthcare professionals
  • 3Primary-care clinics and community health centres
  • 4Pharmacy-based diabetes testing and management services
  • 5Diabetes education and structured self-management programmes
  • 6Monitoring during pregnancy where haematocrit is within the 20-70% range (not for neonates)
  • 7Elderly and long-term chronic disease care
  • 8Point-of-care screening in outreach and rural health programmes

Application video

No application video published yet.

We record application walk-throughs for buyers on request — ask us for a live demo or a custom video of this product in operation.

Request an application video

Manufacturer

S

Sinocare Inc.

Changsha, Hunan · est. 2002 · Brand

Sinocare was founded in Changsha, Hunan in 2002 and is China's first listed blood glucose meter company (SZSE: 300298). It reports being China's No.1 and the world's No.4 blood glucose monitoring company, with 9 global R&D and manufacturing sites, 187 countries and regions served, over 25 million users and 780+ authorised patents. Its portfolio spans blood glucose meters and strips, continuous glucose monitoring, uric acid, HbA1c and point-of-care analysers.

FDA 510(k) K170264 - Gold AQ Blood Glucose Monitoring System (Changsha Sinocare, Inc., 2017-10-05)FDA 510(k) K231476 - TRUENESS AIR / TRUENESS Blood Glucose Monitoring System (Sinocare, Inc., 2023-12-01)ISO 13485 (TUV) and CE certificate stated on the official Sinocare company/store pages (not independently verified in an EU database)

Export markets: 187 countries and regions (official company figure), United States (FDA-cleared blood glucose systems), European Union (CE; EU authorised representative in Germany), Latin America, Middle East, Russia and South Asia

Data sources & verification

Compiled from publicly available sources and last verified on 12 Sept 2026. Specifications can change without notice — confirm with the manufacturer before ordering.

  1. sinocare.com https://www.sinocare.com/en/proinfo_11.html
  2. accessdata.fda.gov https://www.accessdata.fda.gov/cdrh_docs/reviews/K170264.pdf
  3. accessdata.fda.gov https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K170264
  4. madeinchina.com https://www.madeinchina.com/mall/show-Sinocare-Diabetic-Test-Strips-Gold-Aq-Plus-Diabetic-Test-…

Need a variation or OEM version?

Many of these products are available with OEM branding, different voltages or custom configurations. Ask us.